Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Other stock markets
|
Pre-market 01:30:31 | |||
| 177.90 EUR | +2.07% |
|
177.95 | +0.03% |
| 07-28 | SARTORIUS STEDIM BIOTECH : Buy rating from Bernstein | ZD |
| 07-24 | SARTORIUS STEDIM BIOTECH : JP Morgan keeps its Buy rating | ZD |
| Market Cap | 17.31B 20.01B 16.16B 14.83B 27.89B 1,904B 28.33B 190B 74.43B 955B 75.14B 73.5B 3,156B | P/E 2026 * |
45.8x | P/E 2027 * | 35.4x |
|---|---|---|---|---|---|
| Enterprise Value | 19.32B 22.34B 18.04B 16.55B 31.13B 2,126B 31.62B 212B 83.08B 1,065B 83.87B 82.04B 3,522B | EV / Sales 2026 * |
6.18x | EV / Sales 2027 * | 5.5x |
| Free-Float |
28.47% | Yield 2026 * |
0.48% | Yield 2027 * | 0.58% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | +2.07% | ||
| 1 week | +6.72% | ||
| Current month | +6.72% | ||
| 1 month | -0.95% | ||
| 3 months | +8.74% | ||
| 6 months | -0.20% | ||
| Current year | -15.29% |
| 1 week | 169.8 |  | 180.3 |
| 1 month | 158.9 | | 190.8 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 281 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.07% | +6.72% | +6.62% | -33.52% | 20.01B | |
| -0.14% | +2.00% | -19.71% | +2.38% | 187B | |
| +1.44% | +2.07% | -6.16% | +5.09% | 112B | |
| -1.40% | +2.93% | +12.39% | +72.56% | 61.15B | |
| +2.50% | +3.86% | +32.70% | +60.12% | 54.39B | |
| -0.12% | +6.79% | -8.60% | -37.18% | 48.17B | |
| +2.08% | +1.56% | +7.47% | -23.62% | 31.98B | |
| +2.09% | -10.31% | - | - | 30.91B | |
| +1.57% | +3.85% | +46.93% | -11.52% | 24.92B | |
| +2.45% | +3.97% | -2.22% | +4.63% | 23.15B | |
| Average | +1.24% | +2.35% | +7.71% | +4.33% | 59.28B | |
| Weighted average by Cap. | +0.74% | +2.32% | -1.34% | +9.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.61B 2.92B 2.68B 5.04B 344B 5.12B 34.25B 13.44B 172B 13.57B 13.27B 570B | 3.47B 4.01B 3.24B 2.97B 5.58B 381B 5.67B 37.97B 14.9B 191B 15.05B 14.72B 632B |
| Net income | 376M 435M 351M 322M 606M 41.4B 616M 4.12B 1.62B 20.75B 1.63B 1.6B 68.6B | 480M 555M 449M 412M 774M 52.86B 786M 5.26B 2.07B 26.5B 2.09B 2.04B 87.59B |
| Net Debt | 2.01B 2.32B 1.88B 1.72B 3.24B 221B 3.29B 22.03B 8.65B 111B 8.73B 8.54B 367B | 1.77B 2.04B 1.65B 1.52B 2.85B 195B 2.9B 19.38B 7.61B 97.55B 7.68B 7.51B 322B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | €177.90 | +2.07% | 63,610 |
| 26-08-06 | €174.30 | +0.29% | 55,050 |
| 26-08-05 | €173.80 | +0.52% | 62,230 |
| 26-08-04 | €172.90 | +0.58% | 74,728 |
| 26-08-03 | €171.90 | +3.12% | 65,593 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
